HIGHLIGHTS
- who: Lianlei Yang and colleagues from the Department of Gastroenterology, The First People`s Hospital of Linping District, Hangzhou, China have published the research: DLC1 as Druggable Target for Specific Subsets of Gastric Cancer: An RNA-seq-Based Study, in the Journal: Medicina 2023, 59, x FOR PEER REVIEW of 15/07/2022
- what: Apart from several other genes, the authors report DLC1 as a key regulator that can act as a potential biomarker for the diagnosis and therapeutics of gastric carcinoma.
- how: The authors carried out an in-depth analysis of gastric . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.